These findings corroborate those of our study regarding the adiponectin/leptin ratio that showed improvements after RYGB-induced weight loss in patients with severe obesity and T2D. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.